Literature DB >> 3190103

Clinical manifestations and diagnosis of neuroborreliosis.

G Stiernstedt1, R Gustafsson, M Karlsson, B Svenungsson, B Sköldenberg.   

Abstract

Lyme borreliosis has in a few years turned out to be a health problem not only in the United States, but also in many European countries. When it affects the nervous system, Lyme borreliosis acts as the great disease imitator. Because of this characteristic it is often difficult to diagnose on clinical grounds. Patients with neuroborreliosis might appear within all medical disciplines. Clinical markers, such as preceding tick bite and/or ECM, are important clues to the diagnosis. Mononuclear pleocytosis and elevated CSF protein are present in most patients with neuroborreliosis. Final evidence for the diagnosis is the demonstration of specific antibodies in serum and/or CSF. Measurement of antibody titers should be carried out in both serum and CSF, since these methods are complementary when trying to obtain a serological diagnosis of neuroborreliosis.

Entities:  

Mesh:

Year:  1988        PMID: 3190103     DOI: 10.1111/j.1749-6632.1988.tb31837.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

1.  Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi.

Authors:  P A Rosa; D Hogan; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Trigeminal neuralgia as a clinical manifestation of Lyme neuroborreliosis.

Authors:  C Fritz; A Rösler; B Heyden; H J Braune
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

3.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Toward a better understanding of European lyme neuroborreliosis.

Authors:  Gary P Wormser; John J Halperin
Journal:  Clin Infect Dis       Date:  2013-05-10       Impact factor: 9.079

5.  Western immunoblot and flagellum enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.

Authors:  M Karlsson
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis.

Authors:  L Dotevall; L E Rosengren; L Hagberg
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 7.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

9.  The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen.

Authors:  B J Luft; S Mudri; W Jiang; R J Dattwyler; P D Gorevic; T Fischer; P Munoz; J J Dunn; W H Schubach
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans.

Authors:  D W Dorward; T G Schwan; C F Garon
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.